The use of ara as a supplement for a lactating woman

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/202 (2006.01) A23D 9/00 (2006.01) A23L 1/30 (2006.01) A61P 3/02 (2006.01)

Patent

CA 2653503

Edible formulations, such as polyunsaturated fatty acids (PUFAs) such as pharmaceutical compositions or nutritional supplements, are disclosed comprising arachidonic acid (ARA). They are adapted to deliver from 150 mg to 1 g per day of ARA and may contain other PUFAs, for example docosahexaenoic acid (DHA). The DHA dosage is from 400 to 600 mg per day, and the ratio of ARA:DHA may be from 1:5 to 5:1. Pharmaceutical compositions comprising ARA and DHA at a ratio of ARA:DHA of 1:1 to 1:2 are also disclosed, as are foodstuffs comprising 0.1 to 5% ARA. Such formulations can be used to increase ARA levels in vivo, for example in pregnant women or for people who have diseases or conditions associated with low ARA levels.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of ara as a supplement for a lactating woman does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of ara as a supplement for a lactating woman, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of ara as a supplement for a lactating woman will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1488672

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.